US Broker Ratings

Roivant Sciences Ltd. (ROIV) Stock Analysis: Strong Buy Ratings and 15% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) is making waves in the biotechnology sector with its promising pipeline of clinical-stage products and innovative delivery platforms. As a United Kingdom-based biopharmaceutical company, Roivant’s..

Bausch + Lomb Corporation (BLCO): Growth Potential and Analyst Ratings Point to an 11% Upside

Bausch + Lomb Corporation (NYSE: BLCO), a prominent player in the healthcare sector, is attracting investor attention with its potential for growth and strong market positioning. Headquartered in Vaughan, Canada,..

ICON plc (ICLR)

⚠️ No article content returned.

..

RadNet, Inc. (RDNT) Investor Outlook: Capitalizing on a 23.99% Potential Upside in the Booming Diagnostics Sector

RadNet, Inc. (NASDAQ: RDNT) has been making waves in the healthcare sector, particularly in diagnostics and research. With a market capitalization of $5.69 billion, RadNet stands as a significant player..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Tapping into a 25.70% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology industry, offers a compelling case for investors seeking high-growth opportunities in the healthcare sector. With a market capitalization of..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: A 14% Upside Potential with Strong Buy Ratings

West Pharmaceutical Services, Inc. (NYSE: WST) has been making waves in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market capitalization of $24.92 billion,..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 71% Potential Upside Amid Strong Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering biotech firm specializing in RNA interference therapeutics, is capturing investor attention with its robust revenue growth and promising pipeline. Based in Cambridge, Massachusetts,..

Avantor, Inc. (AVTR) Stock Analysis: Insights into a Healthcare Leader’s Potential Upside

Avantor, Inc. (AVTR), a significant player in the healthcare sector, is garnering attention from individual investors due to its diverse offerings and strategic market position. With a market capitalization of..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector

For investors interested in the booming biotechnology industry, Krystal Biotech, Inc. (NASDAQ: KRYS) presents an intriguing opportunity. With a current market cap of $9.66 billion, this Pittsburgh-based company is making..

Incyte Corporation (INCY) Stock Analysis: Strong Revenue Growth and Robust Pipeline Fuel Investor Interest

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, has captured the attention of investors with its impressive revenue growth and promising therapeutic pipeline. With a market capitalization..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: A 32.71% Upside Potential with Robust Revenue Growth

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is garnering significant attention in the investment community, particularly within the healthcare sector. The biopharmaceutical company, known for its innovative treatments targeting central nervous system..

Masimo Corporation (MASI) Investor Outlook: Steady Growth Amidst a Competitive Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices sector, continues to capture investor interest with its robust revenue growth and innovative product offerings in patient monitoring technologies...

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Growth Potential and Analyst Ratings

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, continues to be a stalwart in the global pharmaceutical landscape. With a market capitalization of $317.57 billion, Merck..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating a Healthcare Powerhouse with Limited Upside

Integer Holdings Corporation (NYSE: ITGR), a major player in the healthcare sector, particularly within the medical devices industry, has been a point of interest for investors looking for stability and..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Opportunities in Healthcare with a 6.20% Upside Potential

Fresenius Medical Care AG (NYSE: FMS) stands as a formidable player in the global healthcare sector, particularly within the medical care facilities industry. Based in Bad Homburg, Germany, the company..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Market Volatility with Strong Growth Potential

Inspire Medical Systems, Inc. (NASDAQ: INSP), a leading player in the healthcare sector, has been making waves with its innovative approach to treating obstructive sleep apnea (OSA). As a medical..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a Promising 11.67% Upside Potential in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, is catching the attention of investors with its potential upside of 11.67%, according to analyst ratings. As a key..

Telix Pharmaceuticals Limited (TLX): Investor Outlook with an 83% Potential Upside

Investors with an appetite for innovative biopharmaceutical companies may find Telix Pharmaceuticals Limited (TLX) an intriguing opportunity, especially given its impressive potential upside of 83.25%. As an Australian-based biotechnology firm..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovation with a 5.59% Upside

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, specializes in diagnostics and research, providing a comprehensive range of services and products. With its headquarters in Waltham, Massachusetts, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds